We are proud to have @CedarsSinai recognized in the Honor Roll of the U.S. News & World Report's Annual "Best Hospitals" Rankings for the 9th consecutive year and tied for #1 in California and #1 in Los Angeles! @usnews

The fully virtual 21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies® will be taking place tomorrow! This one day conference will have experts discussing treatments in #melanoma and other skin-related #cancers.

Dr. BJ Rimel @BJRimelMD answers questions regarding a new draft guidance from the U.S. Preventive Services Task Force for high-risk human papillomavirus (#HPV). She emphasizes the importance of screening and the benefit for #cervicalcancer patients.

RT @SekiEki: Vijay Pandyarajan, MD, PhD - American Liver Foundation congrats, Vijay! Thank @americanliverny for the…

RT @jgong15: @DanZhaoMD Summary of our @asco #GI25 abstr below. Thanks @VJOncology for the interview A collab b/t @CSCancerCenter @TempusA…

RT @AGangiMD: A huge thank you to @ESSOnews & @SocSurgOnc for the incredible opportunity as 2024s ICDE recipient! It was an unforgettable…

RT @TheCancerLetter: Ze’ev Ronai (@CSCancerCenter): "It is important to recognize that #CancerResearch has often been a model of using basi…

RT @urotoday: Advances in staging and personalized radiation therapy for high-risk localized #ProstateCancer. @l_ballas @CedarsSinai joins…

RT @DrZuriMurrell: 🎗️ Today is World Cancer Day 🎗️ #WorldCancerDay #StrongerTogether #CancerAwareness #Hope #Support #EarlyDetectionSavesL…

RT @jgong15: Today is #WorldCancerDay thank you @KTLA for this interview & raising cancer awareness @LuParker @glenwalkerktla @CSCancerCe…

Dr. Dan Theodorescu @Dan_Theodorescu is senior author on the @ScienceAdvances paper “Regulation of Volume-Regulated Anion Channels Alters Sensitivity to Platinum #Chemotherapy” describing a promising new drug target to treat platinum-resistant #cancer.

The fully virtual 21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies® will be taking place on February 8th, 2025. This one day conference will have experts discussing treatments in #melanoma and other skin-related #cancers.

RT @OmidHamidMD: FREE Updates for physicians who treat skin cancers. 🌟PER’s 21st Annual Melanoma meeting will bring you up to date on the e…

RT @TheCancerLetter: Cancer research fuels life-saving work, writes @CedarsSinai's Ze'ev Ronai.

RT @mascarleo: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors | Jo…

RT @jgong15: #Tumorboardtuesday case @DrGallent @CSCancerCenter @TumorBoardTues

RT @jgong15: @TumorBoardTues @DrGallent #TumorBoardTuesday Our colleagues in radiation onc @AnthonyNguyenMD @KamravaMD @_katelynatkins @AS…

RT @jgong15: @MPishvaian @DrGallent How do we give triplet tx in the clinic? (ARPI + doce started w/in 6 weeks of #ADT in PEACE-1) @EdwinPo…

RT @UroResidentsCS: 🚨Interested in #ProstateCancer? 📢Announcing a 2-year T32 PCa Training Program @CedarsSinai starting Summer 2025! 👐O…

RT @SFreedlandMD: Interested in #ProstateCancer? 2-yr T32 Prostate Cancer Training Program at Cedars-Sinai starting Summer 2025! Open posit…

Check the #CedarsSinaiCancer website for information on our clinical care and research as well as details on our Training and Education programs, Clinical Trials Office, and our work in the Community!